Categories: DNAEHRNews

Jushi Holdings Inc. to Open Fairfax Dispensary, its 35th Retail Location Nationwide and Fourth Beyond Hello™ Dispensary in Virginia

Jushi Opens Fourth Dispensary in Virginia

Jushi Holdings Inc. announced the opening of its fourth medical cannabis dispensary in Virginia and 35th retail location nationwide. Beyond Hello™ Fairfax will begin serving medical cannabis patients and registered agents on Wednesday, August 31st at 10:00 a.m. in-store and through its digital retail experience at beyond-hello.com

Beyond Hello™ Fairfax Expands Patient Access in Virginia

Located at 10521 Fairfax Blvd. in Fairfax near the corner of Lee Highway and Rt. 123 and just blocks from I-66, Beyond Hello™ Fairfax features 16 traditional and 10 express patient checkouts, along with 45 parking spots with easy in-and-out access to improve patient convenience and accessibility.

Virginia Dispensary to Carry Variety of Medical Cannabis Products

Beyond Hello™ Fairfax will offer dry leaf, concentrates, cartridges, tinctures, topicals, edibles, capsules, pills and various ancillary products such as approved batteries and devices, including The Lab™, The Bank, Sèchè and Tasteology.

 

A Media Snippet accompanying this announcement is available by clicking the image or link above. 

Beyond Hello™ Fairfax to Begin Serving Virginia Medical Cannabis Patients and Registered Agents In-Store and through the Company’s Online Reservation Shopping Experience at beyond-hello.com on Wednesday, August 31st at 10:00 a.m.

BOCA RATON, Fla., Aug. 25, 2022 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced the opening of its fourth medical cannabis dispensary in Virginia and 35th retail location nationwide. Providing an unparalleled in-store and digital retail experience via beyond-hello.com, Beyond Hello™ Fairfax will begin serving medical cannabis patients and registered agents on Wednesday, August 31st at 10:00 a.m. The new store opening comes on the heels of the Company opening Beyond Hello™ Alexandria, which began serving patients on Wednesday, July 27, 2022.

Located at 10521 Fairfax Blvd. in Fairfax near the corner of Lee Highway and Rt. 123 and just blocks from I-66, the new 10,500 square-foot free-standing building features 16 traditional and 10 express patient checkouts, along with 45 parking spots with easy in-and-out access to improve patient convenience and accessibility. Jushi designed Beyond Hello™ Fairfax to serve a growing patient population while offering convenient transaction processing through the Company’s industry-leading online reservation platform – beyond-hello.com.

“Known for its hallmark landscaped and leafy street medians, Fairfax is recognized by Forbes as one of the top places to live in the nation. Beyond Hello™ Fairfax is in a prime location, located in close proximity to George Mason University, a host of shopping centers and independently owned retail shops in the heart of Northern Virginia, and nestled in the suburban expanse of the Washington, D.C. metro region. We are very excited to serve patients in this region and deliver a retail experience that exceeds expectations,” said Jim Cacioppo, Chief Executive Officer, Chairman and Founder of Jushi Holdings Inc.

Cacioppo continued, “On the retail side, we now have four dispensary locations open in Virginia, which have helped to broaden patient access, as well as set the bar for what world class dispensaries and next-gen digital shopping experiences should be. As for the operational side, in the second quarter, we completed phase one of the cultivation expansion of our grower-processor facility in Manassas. In the coming year, we look forward to opening up two more stores to continue to better serve the people of the Commonwealth.”

Joining the Company’s Beyond Hello™ Manassas, Beyond Hello™ Sterling and Beyond Hello™ Alexandria locations, Beyond Hello™ Fairfax will serve patients and registered agents Monday through Saturday from 10:00 a.m. to 8:00 p.m. and on Sunday from 10:00 a.m. to 6:00 p.m. starting on Tuesday, September 13th.

Beyond Hello™ Fairfax will provide patients with an efficient, accessible and safe experience that goes beyond the traditional cannabis dispensing environment. As part of this commitment to exceeding patients’ expectations, a licensed pharmacist, along with experienced, well-trained staff, will be on-site to dispense products, answer questions and provide service to patients and caregivers. This new location will offer dry leaf, concentrates, cartridges, tinctures, topicals, edibles, capsules, pills and various ancillary products such as approved batteries and devices, including The Lab™, The Bank, Sèchè and Tasteology.

About Jushi Holdings Inc.
We are a vertically integrated cannabis company led by an industry-leading management team. In the United States, Jushi is focused on building a multi-state portfolio of branded cannabis assets through opportunistic acquisitions, distressed workouts and competitive applications. Jushi strives to maximize shareholder value while delivering high-quality products across all levels of the cannabis ecosystem. For more information, visit jushico.com or Beyond Hello™ on Instagram and Facebook.

Forward-Looking Information and Statements
This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current conditions but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, involve estimates, projections, plans, goals, forecasts, and assumptions that may prove to be inaccurate. As a result, actual results could differ materially from those expressed by such forward-looking statements and such statements should not be relied upon. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans,” “expects” or “does not expect,” “is expected,” “budget,” “scheduled,” “estimates,” “forecasts,” “intends,” “anticipates” or “does not anticipate,” or “believes,” or variations of such words and phrases or may contain statements that certain actions, events or results “may,” “could,” “would,” “might” or “will be taken,” “will continue,” “will occur” or “will be achieved”. The forward-looking information and forward-looking statements contained herein may include but are not limited to, information concerning the expectations regarding Jushi, or the ability of Jushi to successfully achieve business objectives, and expectations for other economic, business, and/or competitive factors.

By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, the Company has certain expectations and has made certain assumptions. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: the ability of Jushi to successfully and/or timely achieve business objectives, including with regulatory bodies, employees, suppliers, customers and competitors; changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; and compliance with extensive government regulation, as well as other risks and uncertainties which are more fully described in the Company’s Management, Discussion and Analysis for the three months ended March 31, 2022, and other filings with securities and regulatory authorities which are available at www.sedar.com. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.

Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice.

For further information, please contact:

Investor Relations Contact:

Michael Perlman
Executive Vice President of Investor Relations
561-281-0247
Investors@jushico.com

Media Contact:
Ellen Mellody
570-209-2947
ellen@mattio.com

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/f340980b-e844-4c50-a196-b8e7d945966f

https://www.globenewswire.com/NewsRoom/AttachmentNg/9e4d821a-ec12-4b66-9e51-84b55f8baef7

https://www.globenewswire.com/NewsRoom/AttachmentNg/f1e7bee4-cd95-42a6-b75a-0ccc30f99edf

 

Staff

Recent Posts

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

5 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

6 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

6 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

7 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

9 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

9 hours ago